Recombinant Human CIDEA

Este producto es parte de CIDEA - Cell death inducing DFFA like effector A
Product Graph
Contáctenos para saber el precio

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
Recombinant Human CIDEA
category
Proteins and Peptides
provider
FineTest
reference
P8303
tested applications
Western Blot, ELISA

Documents del producto

Instrucciones
Descargar
Data sheet

Product specifications

Category
Proteins and Peptides
Immunogen Target
1-219
Host
E.Coli
Origin
Human
Observed MW
45.3 kDa
Expression
Recombinant
Purity
Greater than 85% by SDS-PAGE gel analyses
Purification
N-terminal His-IF2DI Tag
Size 1
50μg
Size 2
200μg
Size 3
1mg
Form
Lyophilized from a 0.2um filtered solution in PBS with 5% trehalose and 0.06% proclin, pH7.4
Tested Applications
Western Blot, ELISA
Buffer
Centrifuge the vial at 10,000 rpm for 1 minute, reconstitute at 200 μg/ml in Reconstitute with Sterile distilled water
Availability
3-4 weeks
Storage
-20°C for 12 months as lyophilized;2-8°C for 1 month under sterile conditions after reconstitution
UniProt ID
O60543
Alias
CIDE-A, cell death-inducing DFFA-like effector a, cell death inducing DFFA like effector a,CIDEA
Background
Proteins CIDEA
Status
RUO
Note
This product is for research use only.

CIDEA is a lipid droplet-associated protein involved in regulating lipid metabolism and energy homeostasis. It promotes lipid droplet fusion and inhibits lipolysis by modulating the activity of key enzymes such as adipose triglyceride lipase (ATGL). CIDEA is highly expressed in brown adipose tissue, where it contributes to thermogenesis and energy expenditure. Beyond its metabolic functions, CIDEA also plays a role in apoptosis, where it interacts with caspase-activated DNAse to mediate DNA fragmentation. Dysregulation of CIDEA is associated with obesity, insulin resistance, and non-alcoholic fatty liver disease. Research on CIDEA focuses on its dual roles in lipid metabolism and apoptosis, offering potential therapeutic targets for metabolic disorders and cancer.

Related Products

FNab01710

anti- CIDEA antibody

Acts as a CEBPB coactivator in mammary epithelial cells to control the expression of a subset of CEBPB downstream target genes, including ID2, IGF1, PRLR, SOCS1, SOCS3, XDH, but not casein. By interacting with CEBPB, strengthens the association of CEBPB with the XDH promoter, increases histone acetylation and dissociates HDAC1 from the promoter(By similarity). Binds to lipid droplets and regulates their enlargement, thereby restricting lipolysis and favoring storage. At focal contact sites between lipid droplets, promotes directional net neutral lipid transfer from the smaller to larger lipid droplets. The transfer direction may be driven by the internal pressure difference between the contacting lipid droplet pair and occurs at a lower rate than that promoted by CIDEC. When overexpressed, induces apoptosis. The physiological significance of its role in apoptosis is unclear.

Ver Producto
P8303

Recombinant Human CIDEA

Ver Producto
abx006244

Cell Death Activator CIDE-A (CIDEA) Antibody

CIDEA Antibody is a Rabbit Polyclonal Antibody against CIDEA.

Ver Producto